drugset / Trial / NCT01288664
Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a pilot study to evaluate the efficacy and safety of Tacrolimus Sustained-release Capsules (ADVAGRAF) for the induction therapy of Lupus Nephritis (LN) (V, III +V, IV+V).
Timeline
- Start
- 2011-01
- Primary completion
- 2012-12
- Completion
- 2012-12
Outcome
Outcome not reported
Stopped: “sponsor withdraw from this study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | 0.05 mg/kg | — |
| Subject | Tacrolimus | Small molecule | 0.1 mg/kg | — |